Device Varithena_pi

Varithena Administration Pack

Payments companies reported to CMS as associated with Varithena Administration Pack. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$839Kassociated payments (2023-2025)
5,086clinicians with associated payments
1company reporting

By year

2023 $296K
2024 $258K
2025 $285K

Payments reported as associated with Varithena Administration Pack, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $267K
Interventional Cardiology $162K
Vascular & Interventional Radiology $79K
Cardiovascular Disease $42K
Family $36K
Surgery $33K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Varithena Administration Pack

These are the largest totals companies reported as associated with Varithena Administration Pack. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Vinay Satwah Greenbelt, MD Interventional Cardiology $126,539.29
Lina Vargas Abello Windermere, FL Vascular Surgery $63,084.29
Lowell Kabnick Morristown, NJ $38,857.69
Paramjit Chopra Hinsdale, IL Vascular & Interventional Radiology $21,353.78
Misaki Kiguchi Washington, DC Vascular Surgery $20,476.23
Kathleen Gibson Bellevue, WA Vascular Surgery $20,208.76
Michael Lalezarian Los Angeles, CA Vascular & Interventional Radiology $18,924.89
Juan Jimenez Los Angeles, CA Vascular Surgery $17,617.11
Antonios Gasparis Huntington, NY Vascular Surgery $17,253.07
Steven Elias Englewood, NJ Vascular Surgery $16,360.05

Prescribed Varithena Administration Pack?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.